641881099	641881099	CD	B-NP	O
|	|	NN	I-NP	O
LGPH	LGPH	NN	I-NP	O
|	|	NN	I-NP	O
16803216	16803216	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9822665	9822665	CD	B-NP	O
|	|	CC	I-NP	O
4/19/2003	4/19/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
s/p	s/p	NN	I-NP	O
ureteral	ureteral	JJ	I-NP	O
stent	stent	JJ	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/19/2003	4/19/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/16/2003	2/16/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
WIMES	WIMES	NNP	B-NP	O
,	,	,	O	O
JEAN	JEAN	NNP	B-NP	O
M	M	NNP	I-NP	O
856-99-02-2	856-99-02-2	CD	I-NP	O
Tonstin	Tonstin	NNP	I-NP	O
Land	Land	NNP	I-NP	O
Coton	Coton	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
Wark	Wark	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
URO	URO	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/19/03	10/19/03	CD	B-NP	O
AT	AT	NN	I-NP	O
09	09	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SINNING	SINNING	NNP	B-NP	O
,	,	,	O	O
MASON	MASON	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
ELAVIL	ELAVIL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMITRIPTYLINE	AMITRIPTYLINE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/03	2/26/03	CD	B-NP	O
by	by	IN	B-PP	O
BOOCK	BOOCK	NNP	B-NP	O
,	,	,	O	O
KENT	KENT	NNP	B-NP	O
CALVIN	CALVIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
22479218	22479218	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/30/03	4/30/03	CD	B-NP	O
by	by	IN	B-PP	O
FERRUSO	FERRUSO	NNP	B-NP	O
,	,	,	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
NICK	NICK	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
90924638	90924638	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ATENOLOL	ATENOLOL	NNP	B-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/13	1/13	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
COLCHICINE	COLCHICINE	NN	B-NP	O
0.6	0.6	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/13	1/13	CD	I-NP	O
-RRB-	-RRB-	SYM	O	O
GLIPIZIDE	GLIPIZIDE	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ATROVENT	ATROVENT	NN	I-NP	I-protein
INHALER	INHALER	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
IPRATROPIUM	IPRATROPIUM	NN	I-NP	I-protein
INHALER	INHALER	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
NIFEREX-150	NIFEREX-150	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
separate	separate	JJ	B-ADJP	O
from	from	IN	B-PP	O
Levoflox	Levoflox	NNP	B-NP	O
dose	dose	NN	I-NP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
hours	hour	NNS	I-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/03	2/26/03	CD	B-NP	O
by	by	IN	B-PP	O
STATZ	STATZ	NN	B-NP	B-protein
,	,	,	O	O
SHELTON	SHELTON	NNP	B-NP	O
JUDE	JUDE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	B-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
separate	separate	VB	I-VP	O
doses	dose	NNS	B-NP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/03	2/26/03	CD	B-NP	O
by	by	IN	B-PP	O
HISKE	HISKE	NN	B-NP	B-protein
,	,	,	O	O
NICK	NICK	NNP	B-NP	O
GARRY	GARRY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	B-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	B-DNA
PERCOCET	PERCOCET	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
Q6H	Q6H	NN	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
Pain	Pain	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
80	80	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
60	60	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
9	9	CD	B-NP	O
ACARBOSE	ACARBOSE	NN	I-NP	O
25	25	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
250	250	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
2/26/03	2/26/03	CD	B-NP	O
by	by	IN	B-PP	O
GRANO	GRANO	NNP	B-NP	O
,	,	,	O	O
SOLOMON	SOLOMON	NNP	B-NP	O
DARWIN	DARWIN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NIFEREX-150	NIFEREX-150	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
48189866	48189866	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	I-protein
SERIOUS	SERIOUS	NNP	I-NP	I-protein
INTERACTION	INTERACTION	NNP	I-NP	I-protein
:	:	:	O	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	I-protein
&	&	CC	I-NP	I-protein
POLYSACCHARIDE	POLYSACCHARIDE	NNP	I-NP	I-protein
IRON	IRON	NNP	I-NP	I-protein
COMPLEX	COMPLEX	NNP	I-NP	I-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
separate	separate	VB	I-VP	O
doses	dose	NNS	B-NP	O
by	by	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/26/03	2/26/03	CD	B-NP	O
by	by	IN	B-PP	O
FOGT	FOGT	NN	B-NP	O
,	,	,	O	O
NIGEL	NIGEL	NNP	B-NP	O
BRENTON	BRENTON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/30/03	4/30/03	CD	B-NP	O
by	by	IN	B-PP	O
PINCKLEY	PINCKLEY	NNP	B-NP	O
,	,	,	O	O
STANTON	STANTON	NNP	B-NP	O
RENALDO	RENALDO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMITRIPTYLINE	AMITRIPTYLINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
LEVOFLOXACIN	LEVOFLOXACIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COMBIVENT	COMBIVENT	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
FENOFIBRATE	FENOFIBRATE	NNP	I-NP	O
54	54	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
URISED	URISED	VBD	B-VP	O
2	2	CD	B-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Morgan	Morgan	NNP	I-NP	O
Segui	Segui	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
to	to	TO	I-VP	O
scheudle	scheudle	VB	I-VP	O
appointment	appointment	NN	B-NP	O
2-3	2-3	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Verma	Verma	NNP	I-NP	O
,	,	,	O	O
call	call	VBP	B-VP	O
to	to	TO	I-VP	O
schedule	schedule	VB	I-VP	O
appointment	appointment	NN	B-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Delang	Delang	NNP	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
appointment	appointment	NN	B-NP	O
next	next	IN	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Forniceal	Forniceal	NNP	B-NP	O
Rupture	Rupture	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
s/p	s/p	NN	I-NP	O
ureteral	ureteral	JJ	I-NP	O
stent	stent	JJ	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
lad	lad	VBD	B-VP	O
stent	stent	JJ	B-NP	O
2/14	2/14	CD	I-NP	O
dm	dm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperchol	hyperchol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevated	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
emphysema	emphysema	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
sick	sick	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Placement	Placement	NN	B-NP	O
right	right	JJ	I-NP	O
ureteral	ureteral	JJ	I-NP	O
stent	stent	NN	I-NP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Carrol	Carrol	NNP	I-NP	O
Dezzutti	Dezzutti	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
69M	69M	NN	B-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
AAA	AAA	NN	I-NP	O
present	present	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
from	from	IN	B-PP	O
ureteroscopy	ureteroscopy	NN	B-NP	O
at	at	IN	B-PP	O
DUMC	DUMC	NN	B-NP	B-cell_type
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
forniceal	forniceal	JJ	B-NP	O
rupture	rupture	NN	I-NP	O
with	with	IN	B-PP	O
flank	flank	NN	B-NP	O
and	and	CC	I-NP	O
groin	groin	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

To	To	TO	B-PP	O
OR	OR	NN	B-NP	B-protein
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
for	for	IN	B-PP	O
ureteral	ureteral	JJ	B-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Procedure	Procedure	NN	B-NP	O
without	without	IN	B-PP	O
complications	complication	NNS	B-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

Stent	Stent	NN	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
drain	drain	VB	I-VP	O
bloody	bloody	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
during	during	IN	B-PP	O
procedure	procedure	NN	B-NP	O
.	.	.	O	O

Post-op	Post-op	JJ	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
mild	mild	JJ	B-NP	O
flank	flank	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

POD	POD	NN	B-NP	B-protein
#	#	#	I-NP	I-protein
1	1	CD	I-NP	I-protein
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
eposide	eposide	NN	B-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
to	to	TO	B-PP	O
90/45	90/45	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
postural	postural	JJ	I-NP	O
dizziness	dizziness	NN	I-NP	O
.	.	.	O	O

Sx	Sx	NN	B-NP	O
and	and	CC	I-NP	O
signs	sign	NNS	I-NP	O
resoved	resove	VBD	B-VP	O
with	with	IN	B-PP	O
Po	Po	NNP	B-NP	O
fluids	fluid	NNS	I-NP	O
and	and	CC	O	O
holding	hold	VBG	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
atenolol	atenolol	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
on	on	IN	B-PP	O
POD	POD	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
2	2	CD	I-NP	I-protein
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
,	,	,	O	O
tolerating	tolerate	VBG	B-VP	O
PO	PO	NN	B-NP	B-protein
and	and	CC	B-PP	O
without	without	IN	B-PP	O
dizziness	dizziness	NN	B-NP	O
or	or	CC	I-NP	O
hypotension	hypotension	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
may	may	MD	B-VP	O
experience	experience	VB	I-VP	O
soem	soem	NN	B-NP	O
flank	flank	NN	I-NP	O
and	and	CC	O	O
groin	groin	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
pain	pain	NN	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
esperience	esperience	VBP	B-VP	O
severe	severe	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
or	or	CC	I-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
department	department	NN	I-NP	O
.	.	.	O	O

Call	Call	NNP	B-NP	O
Urology	Urology	NNP	I-NP	O
clinic	clinic	NN	I-NP	O
for	for	IN	B-PP	O
questions	question	NNS	B-NP	O
or	or	CC	I-NP	O
concerns	concern	NNS	I-NP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

Schedule	Schedule	NNP	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Heldreth	Heldreth	NNP	I-NP	O
regarding	regard	VBG	B-VP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
aneurysm	aneurysm	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SURETTE	SURETTE	NNP	B-NP	O
,	,	,	O	O
OSWALDO	OSWALDO	NNP	B-NP	O
WILLARD	WILLARD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IF52	IF52	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/19/03	10/19/03	CD	I-NP	O
@	@	SYM	B-NP	O
09	09	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

